Physician profile
Michael Kammerer
NPI 1932350287
$2,028.30
in general payments reported to CMS, 2019-2025
23 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $14.20 · 2021: $401 · 2022: $497 · 2023: $597 · 2024: $256 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $382.37 | 2021-2025 | Wegovy |
| Intuitive Surgical, INC. | $264.32 | 2019-2025 | Da Vinci Surgical System |
| Teleflex LLC | $239.01 | 2023 | Deknatel, Weck, Titan Sgs Standard Gastric Stapler |
| Baxter Healthcare | $174.89 | 2021-2023 | Tisseel, Floseal |
| W. L. Gore & Associates, INC. | $141.68 | 2021 | |
| Endo Pharmaceuticals INC. | $140.87 | 2021-2024 | Nascobal |
| Davol INC. | $110.39 | 2022 | |
| Lilly USA, LLC | $63.70 | 2024-2025 | Zepbound |
| Integra Lifesciences Corporation | $60.00 | 2023-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $51.39 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Standard Bariatrics, INC. | $50.58 | 2022 | |
| Phathom Pharmaceuticals, INC. | $50.49 | 2024-2025 | Voquezna |
| Smith+Nephew, INC. | $48.92 | 2019 | |
| Intra-Sana Laboratories | $43.84 | 2022-2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Laborie Medical Technologies Corp. | $43.65 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $35.21 | 2022 | |
| Ethicon US, LLC | $27.52 | 2024 | Harmonic, Stratafix |
| Kci USA, INC. | $18.28 | 2019 | |
| Olympus America INC. | $17.83 | 2021 | |
| Innocoll Pharmaceuticals Limited | $17.70 | 2021 | |
| Lsi Solutions INC | $15.93 | 2024 | Cor-Knot |
| Endogastric Solutions, INC | $15.53 | 2024 | Esophyx |
| Acell, INC. | $14.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kammerer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.